Page 8 - கார்னெல் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

December 10, 2020
A Cornell-led COVID-19 patient registry, organized by Weill Cornell Medicine physicians and scientists in response to surging cases earlier this year in New York City, continues to be a source of medical insight into the workings of the novel coronavirus and treatment of infected patients.
John Abbott/Weill Cornell Medicine
Dr. Monika Safford, chief of Weill Cornell Medicine’s Division of General Internal Medicine and the John J. Kuiper Professor of Medicine, was one of the co-leaders in developing the COVID-19 patient registry.
Illustrating the power of interdisciplinary cross-campus collaboration, a team of Weill Cornell Medicine physicians and scientists based in New York City, along with student statisticians collaborating remotely from Cornell’s Ithaca campus and elsewhere, have built a secure database with medical data on more than 4,000 patients who had clinical symptoms of COVID-19 and were seen at one of three NewYork-Presbyte ....

New York , United States , Monika Safford , Johnj Kuiper , Weill Cornell Medicine Division , Weill Cornell Medicine , New York City , General Internal Medicine , New York Presbyterian Hospital , Cornell Medicine , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , மோனிகா குங்குமப்பூ , வெயில் கார்னெல் மருந்து பிரிவு , வெயில் கார்னெல் மருந்து , புதியது யார்க் நகரம் , ஜநரல் உள் மருந்து , புதியது யார்க் ப்ரெஸ்பிடீரியந் மருத்துவமனை , கார்னெல் மருந்து ,